ClinicalTrials.Veeva

Menu

Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance

U

University of Kiel

Status

Completed

Conditions

Healthy

Treatments

Other: high protein diet
Other: moderate protein diet

Study type

Interventional

Funder types

Other

Identifiers

NCT05337007
ABW-2022-HP

Details and patient eligibility

About

Aim of the study is to investigate the effects of high-protein, ultraprocessed foods on the regulation of energy balance in a metabolic chamber. The primary outcome parameter of the study is the energy balance (ad libitum energy intake and energy expenditure).

Full description

Each of the two study weeks starts with a 3-day run-in period with controlled diet at home, following 48 hours in a metabolic chamber. On the day the participants leave the metabolic chamber, they keep a food record over the rest of the day at home.

  1. week: meals containing 30 % protein (80 % ultraprocessed high-protein foods), physical activity level (PAL) 1.45, 2 intervention days in the metabolic chamber: ad libitum energy intake
  2. week: meals containing 13 % protein (80 % ultraprocessed foods with moderate protein content), physical activity level (PAL) 1.45, 2 intervention days in the metabolic chamber: ad libitum energy intake

Enrollment

24 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy
  • BMI 19-29 kg/m2
  • low-medium habitual physical activity
  • women with regular menstrual cycle (during intervention in follicular phase)

Exclusion criteria

  • smoking
  • chronic illnesses (e.g. renal dysfunction)
  • regular intake of medication
  • food allergies / intolerances
  • vegans and vegetarians
  • regular high physical activity (exercise >1 hour/d)
  • current weight loss diet / weight loss of >5 kg in the last 3 months
  • pregnant / lactating women
  • persons incapable of giving informed legal consent
  • restraint eaters (according to the German version of the 'Three-Factor-Eating-Questionnaire', Stunkard und Messick (1985))

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

24 participants in 2 patient groups

dietary intervention, high protein diet
Experimental group
Description:
commercially available high protein ultraprocessed food items (30% protein content), cross-over design, all subjects receive all interventions
Treatment:
Other: high protein diet
dietary intervention, moderate protein diet
Active Comparator group
Description:
commercially available moderate protein ultraprocessed food items (13% protein content), cross-over design, all subjects receive all interventions
Treatment:
Other: moderate protein diet

Trial contacts and locations

1

Loading...

Central trial contact

Anja Bosy-Westphal, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems